Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.489
+0.029 (6.30%)
Dec 3, 2024, 12:28 PM EST - Market open
Entero Therapeutics Market Cap
Entero Therapeutics has a market cap or net worth of $2.32 million as of December 3, 2024. Its market cap has decreased by -35.42% in one year.
Market Cap
2.32M
Enterprise Value
63.66M
1-Year Change
-35.42%
Ranking
Category
Stock Price
Market Cap Chart
Since October 11, 2016, Entero Therapeutics's market cap has decreased from $49.20M to $2.32M, a decrease of -95.27%. That is a compound annual growth rate of -31.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 2.20M | -21.43% |
| Dec 29, 2023 | 2.80M | -45.10% |
| Dec 30, 2022 | 5.10M | -71.67% |
| Dec 31, 2021 | 18.00M | -38.98% |
| Dec 31, 2020 | 29.50M | 8.46% |
| Dec 31, 2019 | 27.20M | 32.68% |
| Dec 31, 2018 | 20.50M | -51.19% |
| Dec 29, 2017 | 42.00M | -7.89% |
| Dec 30, 2016 | 45.60M | -7.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helius Medical Technologies | 2.30M |
| Venus Concept | 2.27M |
| cbdMD | 2.23M |
| Tivic Health Systems | 2.21M |
| Virpax Pharmaceuticals | 2.20M |
| Sonnet BioTherapeutics Holdings | 2.19M |
| Salarius Pharmaceuticals | 2.13M |
| IMAC Holdings | 1.91M |